Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIn the UK private market, Mounjaro weight loss pricing varies considerably by dose and provider — typically ranging from around £149 to £375 per month since Eli Lilly raised its list price in September 2025, when the highest-dose pen's list price moved from roughly £122 to around £330. These figures are reported market figures, hedged against what any given clinic charges. Mounjaro (tirzepatide) is a Prescription-Only Medicine: a GPhC-registered Independent Prescriber must assess your suitability before a prescription can be issued, so the price of treatment is always inseparable from the cost of proper clinical oversight.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The number you see on a price-comparison search rarely tells the full story. Some providers quote the cost of the pen alone, then add a consultation fee, a prescription charge, and a delivery charge at checkout. Others bundle everything. The difference between a £149 headline and a £220 total bill comes down to what's included, and that gap matters when you're budgeting month to month.
Eli Lilly's September 2025 price increase shifted the landscape significantly. The list price for the highest maintenance dose rose by roughly £200 per pen compared with earlier 2025 figures, and most private providers adjusted accordingly. As reported widely at the time, pens at the top of the schedule now carry list prices around £330; clinical services stack their margin and service costs on top of that. If you're comparing options, the true monthly cost of Mounjaro is the all-in number, not the pen price alone.
Lower doses cost less per pen. Someone starting at 2.5mg pays a different amount than someone stabilised at 10mg or 15mg. A 2.5mg price comparison and a 5mg price comparison look meaningfully different, and the dose your prescriber recommends depends on your clinical picture, not your preference.
Four costs frequently sit outside the advertised figure: the initial consultation, the prescription fee, delivery, and aftercare support. Some platforms charge separately for each clinical review before a repeat order. Others charge for dose-increase assessments. A few add administration fees for GP notification letters.
Aftercare is worth thinking about carefully. Mounjaro is titrated over weeks and months; most people have questions during that time, about side effects, about what to do if a dose is delayed, about whether a symptom is normal. If that support costs extra, the economics change. Our FAQs give a sense of what the ongoing clinical relationship looks like in practice.
Delivery timing is another one. Some providers post via standard mail; others use tracked couriers. If you order on a Friday and your pen needs refrigeration, the logistics matter. Payday falls on different days for different people, and a Monday order placed before noon works differently from one placed on a Thursday afternoon, something worth factoring into how you plan.
Cheapest isn't a race we entered. That's a deliberate choice, not an oversight. One transparent price covers everything: the consultation, the prescription, the medicine, next-working-day DPD delivery in plain packaging, and seven-day aftercare with clinical re-review before each repeat. No add-ons emerge at checkout.
Our GPhC-registered pharmacy (registration number 9012878, verifiable at the GPhC register) sources Mounjaro through the licensed UK supply chain. Every consultation is read by a named GPhC-registered Independent Prescriber the same day, a real clinician makes the call. If you want to see exactly what each dose costs before committing, our Mounjaro price page sets out the current figures clearly. We don't publish per-pen prices in article copy because pricing can move and we'd rather you see the live figure.
If you want to explore how tirzepatide compares with other licensed options, the weight loss treatment overview lays that out clearly.
The MHRA has documented raids on illicit UK manufacturing sites producing counterfeit tirzepatide pens, and seized roughly 20 million doses of illegally traded weight-loss medicines worth around £45 million. Fake pens have been found to contain incorrect substances. The consistent pattern across those cases: low prices, sellers operating without a verifiable pharmacy registration, and medicines supplied without proper clinical assessment.
The MHRA's Yellow Card scheme allows anyone to report a suspect seller, and NICE's appraisal of tirzepatide (TA1026) makes clear these medicines belong inside a supervised clinical pathway. A small saving against a genuine regulated price answers the wrong question entirely. The right question is whether you're getting a real medicine, clinically assessed, from a pharmacy you can look up. That's the metric that keeps you safe.
If you're researching the broader UK pricing landscape, our Mounjaro weight loss injections price comparison covers what different providers typically include, and our Mounjaro price comparison goes further in showing how to read the numbers critically across the market.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.